Single and Multiple Ascending Dose Study to Assess the Safety, Tolerability and PK of ONO-2910 in Japanese and Caucasian Subjects
Clinical trial NCT04504760 · COMPLETED
Trial details
- NCT number
- NCT04504760
- Sponsor
- Ono Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-10
- Primary completion
- 2021-03-18
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.